Organigram GlobalSTU:0OG -0.85%60 PB Ratio is 0.47 as of Jun. 26, 2026, which is 61% below its 10-year median of 1.19. GuruFocus rates STU:0OG with a GF Score™ of 60/100 and a GF Value™ of €1.46 (Possible Value Trap). The stock has 1 warning sign investors should review. Among 922 Drug Manufacturers companies, Organigram Global ranks better than 91.11% on this metric.
Organigram Global Inc stock PB Ratio (=0.5) is close to 1-year low of 0.5.
The historical rank and industry rank for Organigram Global's PB Ratio or its related term are showing as below:
STU:0OG'
s PB Ratio Range Over the Past 10 Years
Min: 0.36 Med: 1.19 Max: 8.42
Current: 0.5
During the past 13 years, Organigram Global's highest PB Ratio was 8.42. The lowest was 0.36. And the median was 1.19.
STU:0OG's PB Ratio is ranked better than 91.11% of 922
companies
in the Drug Manufacturers industry
Industry Median: 1.825
vs STU:0OG: 0.50
During the past 12 months, Organigram Global's average Book Value Per Share Growth Rate was -6.60% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -26.10% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -20.90% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 41.20% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Organigram Global was 544.10% per year. The lowest was -26.10% per year. And the median was 31.40% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Organigram Global PB Ratio Related Terms
Organigram Global PB Ratio Historical Data
* Premium members only.
The historical data trend for Organigram Global's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Organigram Global's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Organigram Global PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Organigram Global's PB Ratio distribution charts can be found below:
* The bar in red indicates where Organigram Global's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Organigram Global (STU:0OG) has a PB Ratio of 0.47 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Organigram Global and its competitors. This is 61% below median its historical median of 1.19. Over the past decade, Organigram Global's PB Ratio has ranged from 0.36 to 8.42. According to the industry distribution chart, Organigram Global ranks #82 out of 922 companies in the Drug Manufacturers industry, placing it in the top 8.9%.
Is Organigram Global's PB Ratio too high?
Organigram Global's current PB Ratio of 0.47 is 61% below median its 10-year median of 1.19. Over the past 10 years, this metric has ranged from a low of 0.36 to a high of 8.42. The Drug Manufacturers industry median PB Ratio is 1.83. Organigram Global's value of 0.47 is 74.2% below this industry median. Based on the distribution chart, Organigram Global ranks #82 out of 922 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Organigram Global has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Organigram Global's PB Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Organigram Global ranks #82 out of 922 companies for PB Ratio. This places Organigram Global in the top 9% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.83. Organigram Global's value of 0.47 is 74.2% below this benchmark. Historically, Organigram Global's own PB Ratio has ranged from 0.36 to 8.42 over the past decade. While the company's 10-year median is 1.19 vs. the industry median of 1.83, Organigram Global has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.83, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Organigram Global's current PB Ratio of 0.47 is 74.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Organigram Global and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Organigram Global's current PB Ratio is 0.47, which is 61% below median its own 10-year median of 1.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Organigram Global stock overvalued right now?
Based on GuruFocus' analysis, Organigram Global (STU:0OG) is currently considered Possible Value Trap. The stock's GF Value™ is €1.46, compared to a current price of €0.82 — trading 44.1% below its estimated fair value. The current PB Ratio is 0.47, which is 61% below median its 10-year median of 1.19 and 74.2% below the Drug Manufacturers industry median of 1.83. Organigram Global's overall GF Score™ is 60/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Organigram Global (STU:0OG), the current PB Ratio is 0.47 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Organigram Global (STU:0OG) Overvalued in 2026?
Based on GuruFocus' analysis, Organigram Global stock appears to be undervalued.
The current stock price of €0.82 is trading 44.1% below its estimated GF Value™ of €1.46.
GuruFocus considers Organigram Global to be Possible Value Trap.
Key valuation signals for STU:0OG:
PB Ratio: 0.47 (61% below median its 10-year median of 1.19)
GF Value™: €1.46 vs. price of €0.82 (44.1% below fair value)
Industry Position: 74.2% below the Drug Manufacturers median (#82 of 922)
No single metric tells the full story. See the STU:0OG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
60GF Score
Get the complete analysis for STU:0OG
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:0OG has been successfully added to your 
